BLK News 321.55 08/20/2014 04:45:17 Blackrock (BLK)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Blackrock (BLK) 321.55 $BLK

IShares, Pimco, ALPS Set To Close 26 ETFs By October
at Investor's Business Daily - Tue Aug 19, 5:38PM CDT
Three ETF providers announced a slew of fund closings last week. IShares, the world's largest manager of exchange traded funds, will shutter 18 ETFs , including 10 target-date funds. In a statement on Aug. 15, parent company BlackRock (BLK) said that...

Insider Trading Alert - BLK, WBMD And CIM Traded By Insiders
at The Street - Tue Aug 19, 9:15AM CDT
Stocks with insider trader activity include BLK, WBMD and CIM

Quarterly Financial Results, Appointments, Dividend Announcements, and New Products - Research Reports on AmericanTower, Allstate, BlackRock, State Street and ACE
PR Newswire - Fri Aug 15, 8:00AM CDT
Today, Analysts Review released its research reports regarding American Tower Corporation (NYSE: AMT), The Allstate Corporation (NYSE: ALL), BlackRock, Inc. (NYSE: BLK), State Street Corporation (NYSE: STT) and ACE Limited (NYSE: ACE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5769-100free.

Valuation of Assets of the iShares Silver Trust Following the Suspension of the London Silver Fix
Business Wire - Thu Aug 14, 4:59PM CDT
iShares Delaware Trust Sponsor LLC, in its capacity as sponsor of iShares Silver Trust (SLV), is notifying shareholders regarding a change in the pricing source used in the evaluation of SLV's silver.

Alternative Mutual Funds Under SEC Scrutiny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 3:24PM CDT
The U.S. Securities and Exchange Commission (SEC) came up with the regulatory examination of alternative mutual funds. These mutual funds, proposed to be more risky than standard ones, have raised concerns regarding their compliance with leverage and liquidity rules.

BlackRock Rises; SEC To Sweep Alternative Funds
at Investor's Business Daily - Wed Aug 13, 10:54AM CDT
Regulators are looking into alternative mutual funds, according to sources cited in a Wall Street Journal report late Tuesday. The Securities and Exchange Commission is investigating brokerages such as BlackRock (BLK) and AQR Capital Management to...

BlackRock(R) Announces August Cash Distributions for the iShares(R) Funds
Marketwire - Wed Aug 13, 7:04AM CDT
(TSX: CBD), (TSX: CBD.A), (TSX: CBH), (TSX: CBH.A), (TSX: CBN), (TSX: CBN.A), (TSX: CBO), (TSX: CBO.A), (TSX: CDZ), (TSX: CDZ.A), (TSX: CEW), (TSX: CEW.A), (TSX: CHB), (TSX: CHB.A), (TSX: CLF), (TSX: CLF.A), (TSX: CLG), (TSX: CLG.A), (TSX: CMR), (TSX: CMR.A), (TSX: CPD), (TSX: CPD.A), (TSX: CSD), (TSX: CSD.A), (TSX: CUD), (TSX: CUD.A), (TSX: CVD), (TSX: CVD.A), (TSX: CYH), (TSX: CYH.A), (TSX: FIE), (TSX: FIE.A), (TSX: XBB), (TSX: XCB), (TSX: XDV), (TSX: XEB), (TSX: XEI), (TSX: XFN), (TSX: XFR), (TSX: XGB), (TSX: XHB), (TSX: XHD), (TSX: XHY), (TSX: XIG), (TSX: XLB), (TSX: XPF), (TSX: XQB), (TSX: XQB.A), (TSX: XRE), (TSX: XSB), (TSX: XSH), (TSX: XSQ), (TSX: XTR), (TSX: XUT)

BlackRock Launches Multi-Manager Alternative Strategies Fund
Business Wire - Tue Aug 12, 12:00PM CDT
BlackRock launched the BlackRock Multi-Manager Alternative Strategies Fund (BMMAX) (the "Fund" , designed to offer individual investors the opportunity to access multiple alternative investment strategies in a single open-end mutual fund. The investment objective of the Fund is to seek total return. BMMAX extends BlackRock's alternative mutual fund platform to seven funds, further establishing the firm as one of the preeminent providers of alternative investment solutions globally, with more than $115 billion in assets under management (at 6/30/14).

CME Group and Thomson Reuters Confirmed by the London Bullion Market Association as the Administrators of the London Silver Price
Marketwire - Mon Aug 11, 4:43PM CDT
iShares (TSX: SVR)(TSX: SVR.C), the industry-leading exchange-traded fund (ETF) business at BlackRock Asset Management Canada Limited (BlackRock Canada), an indirect, wholly-owned subsidiary of BlackRock, Inc. (BlackRock), is notifying unitholders of iShares Silver Bullion ETF (SVR) regarding a change in the pricing source used in the valuation of silver bullion.

Watch for BlackRock to Potentially Pullback After Gaining 1.59% Yesterday
Comtex SmarTrend(R) - Fri Aug 08, 4:29PM CDT
BlackRock (NYSE:BLK) traded in a range yesterday that spanned from a low of $302.61 to a high of $308.11. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $307.74 on volume of 391,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.59% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Aug 08, 4:28PM CDT
BlackRock (NYSE:BLK) traded in a range yesterday that spanned from a low of $302.61 to a high of $308.11. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $307.74 on volume of 391,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Capital Markets Stocks Technical Review -- Fortress Investment, BlackRock, Legg Mason, Eaton Vance, and Prospect Capital
PR Newswire - Fri Aug 08, 7:50AM CDT
On Thursday, August 07, 2014, the NASDAQ Composite ended at 4,334.97, down 0.46%, the Dow Jones Industrial Average finished the day 0.46% lower at 16,368.27, and the S&P 500 closed at 1,909.57, down 0.56%. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Financials Sector Index ended the day at 298.11, down 0.53%, and the index has declined 3.55% in the last one month. Investor-Edge has initiated coverage on the following equities: Fortress Investment Group LLC (NYSE: FIG), BlackRock Inc. (NYSE: BLK), Legg Mason Inc. (NYSE: LM), Eaton Vance Corporation (NYSE: EV), and Prospect Capital Corporation (NASDAQ: PSEC). Free research on these five companies can be accessed at:

JPMorgan's $4.5B Mortgage Accord Approved by Trustees - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 5:00PM CDT
JPMorgan's (JPM) $4.5-billion mortgage securities deal with nearly 21 institutional investors has been approved by the trustees of the securities.

Goldman Aims Perzo as Alternate to 'Instant Bloomberg' - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 3:35PM CDT
In an effort to find an alternative to 'Instant Bloomberg' -- the messaging service that currently dominates trading communications ??? several major Wall Street firms led by The Goldman Sachs Group, Inc. (GS) are nearing a deal to acquire stake in a chat and instant messaging startup, Perzo Inc.

Mobileye Surges After IPO: Tech Winners & Losers
at The Street - Mon Aug 04, 11:01AM CDT
Mobileye shares rose after a strong IPO, while Groupon shares rose ahead of earnings and Apple shares fell slightly following speculation about an e-commerce partnership with Visa.

Fortress Investment Up on Earnings Beat & Special Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 10:20AM CDT
Shares of Fortress Investment gained 1.5% after it reported second-quarter 2014 pre-tax distributable earnings of 39 cents per share, up 30% year over year. Moreover, results outpaced the Zacks Consensus Estimate of 34 cents.

Invesco (IVZ) Beats Q2 Earnings on Strong Revenues, AUM Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 11:33AM CDT
Driven by impressive top-line growth, Invesco (IVZ) reported second-quarter 2014 adjusted earnings of 65 cents per share.

Waddell & Reed Falls Despite Earnings Beat and Revenue Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 11:30AM CDT
Shares of Waddell & Reed (WDR) fell 4.2% with the concern of rising expenses following the second-quarter 2014 earnings release.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading